Uros Markovic

20PUBLICATIONS
67CO-AUTHORS
Molecular targetsAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)ChiropracticCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 27, 2026
Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact (D-IMPACT) Project.

|May 09, 2026
Incidence of infections in patients treated with rituximab for autoimmune disorders of hematological Interest or non-Hodgkin lymphoma.

|Apr 16, 2026
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

|Aug 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.

Andrea Duminuco, Patrick Harrington, Vittorio Del Fabro

|Jul 12, 2025
COVID-19 Vaccine Experience: Loss of Humoral Response Following Autologous Stem Cell Transplantation in Multiple Myeloma Patients and Positive Effect of Booster Dose.

Uros Markovic, Elvira Scalisi, Giuliana Giunta

|Mar 13, 2025
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level.

Fabio Stagno, Stefania Stella, Salvatore Leotta

Pageof 4

Frequent Collaborators

6 joint publications

Alessandra Romano

5 joint publications

Andrea Duminuco

4 joint publications

Salvatore Leotta

4 joint publications

Giuseppe Alberto Palumbo